The Sofia 2 SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia 2 SARS Antigen FIA, with the Sofia 2 analyzer, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.

Quidel Corporation

San Diego

Quidel Corporation startup from San Diego, United States is ranked 572 out of 2450 worldwide and 208 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map